论文信息 - BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naïve mantle cell lymphoma. - 字舞流文

BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naïve mantle cell lymphoma.

A. Ruppert | M. Dreyling | C. Cheah | Yucai Wang | W. Jurczak | J. Sharman | T. Eyre | N. Shah | R. Ito | M. Gandhi | D. Andorsky | C. Chay | Yuqin Song | Michael L. Wang | Hannah M Messersmith | Valerie A Muthig | Valerie A. Muthig